Please try another search
Heart Test Laboratories, Inc., doing business as HeartSciences, is a medical technology company focuses on applying AI-based technology to an ECG to expand and improve an ECG's clinical utility. It is developing AI-ECG solutions to be made available on a hardware agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is designed to provide diagnostic information related to cardiac dysfunction. The MyoVista also provides conventional ECG information in the same test. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
Name | Age | Since | Title |
---|---|---|---|
Andrew Simpson | 54 | 2012 | CEO, President & Chairman of the Board of Directors |
Mark T. Hilz | 64 | 2013 | COO, Secretary & Director |
Brian Szymczak | 50 | 2014 | Independent Director |
Bruce Robert-Paul Bent | 67 | 2020 | Independent Director |
David R. Wells | 61 | 2022 | Independent Director |
Benjamin Glicksberg | - | 2024 | Member of Scientific Advisory Board |
Jordan B. Strom | - | 2024 | Member of Scientific Advisory Board |
Partho P. Sengupta | - | 2024 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review